Official Launch of the JPIAMR Strategic Research Agenda “THE MICROBIAL CHALLENGE –
AN EMERGING THREAT TO HUMAN / ANIMAL HEALTH
Towards a Global Research Agenda for AMR
OBJECTIVES
To achieve wide recognition and awareness for the findings and roadmap of the JPIAMR Strategic Research Agenda (SRA)
To encourage uptake of the recommendations developed in the SRA by a wide range of stakeholders
To encourage a follow-up and future collaboration between research funding agencies in the field of Antimicrobial Resistance
To encourage the participation of private funders
To discuss among international partner funders of key priorities of the SRA and what is relevant for them by developing global funding opportunities
To work towards a global Joint Programming Initiative
3 April 2014 |Brussels|Belgium
De Warande Room Salon Lode Baron Campo|Zinnerstraat 1|1000 Brussels
Official Launch event of the JPIAMR Strategic Research Agenda
PROGRAMME
Thursday April 3 2014
Opening session
Moderator/Introducer: Fulvio Esposito, Chair GPC and Head of Technical Secretariat of the Minister for Education, University and Research, Italy
09.30 Welcome Address │ Lena Furmark │ State Secretary, Ministry of Health and Social Affairs, Sweden
09.45 Welcome Address │ Máire Geoghegan-Quinn │ European Commissioner for Research, Innovation and Science (recorded video)
10.10 Why is AMR a human threat? │Carmem Pessoa │ Head of the AMR unit, World Health Organization
10.30 Why a Joint Programming Initiative on AMR │ Mats Ulfendahl │ MB Chair, Swedish Research Council
10.50 COFFEE BREAK – Salon Lode Baron Campo
SRA Presentation session: The JPIAMR Strategic Research Agenda
Moderator: Bertrand Schwartz (ANR) and Laurent Gutmann Head of microbiological Laboratory at the
European Hospital Georges Pompidou, INSERM, France
11.20 The JPIAMR Strategic Research Agenda│ Herman Goossens │ SAB Chair, University of Antwerp
11.45 The UK strategy for antimicrobial resistance (AMR) and its implications for research and development|
John Watson|Deputy Chief Medical Officer at the Department of Health, United Kingdom
12.10 Reflections on the SRA from the industry point of view │ Richard Bergström │ Director, EFPIA
12.35 Open discussion
60 min Lunch Break
Session 1: Funding of AMR programmes
Moderator: André Van der Zande, Director-General at RIVM, The Netherlands
Scope:
Presentation mapping analysis on AMR funding
Presentation of AMR funding schemes by countries
Questions for the presentations:
Which are the common denominators of funding schemes
Areas for coordination/collaboration: gap analysis
Opportunities for global funding initiatives: Which is the type of research that needs to be
funded at a global level?
14.00 Funding AMR research: the British approach│ Sir John Savill| Chief Executive of the Medical Research Council,
United Kingdom
Official Launch event of the JPIAMR Strategic Research Agenda
14.15
NIH´s antibacterial resistance program| Dennis M. Dixon|Chief, Bacteriology and Mycology Branch, National
Institute of Allergy and Infectious Diseases, NIH, USA
14.30
14.45
The South African perspective on the antimicrobial resistance challenge| Niresh Bhagwandin| Executive
Manager: Strategic Research Initiatives, South African Medical Research Council
Antimicrobial resistance; the Canadian perspective| Alain Beaudet| President, Canadian Institutes of Health
Research, Canada
15.00
15.30
Debate: Gaps and needs | Debate: Relationships with public funding
COFFEE BREAK – Salon Lode Baron Campo
Session 2: Implementing the SRA: opportunities for global funding
Moderator: Marc Ouellette, Scientific Director, Canadian Institutes of Health Research, Canada
Scope:
Presentation of AMR funding schemes by countries/agencies by SRA topics that needs a global
action
Questions for the presentations:
Which are the common denominators of funding schemes
Areas for coordination/collaboration: gap analysis
Opportunities for global funding initiatives: Which is the type of research that needs to be
funded at a global level?
16.00 Australia’s response to the threat of antimicrobial resistance|Warwick Anderson| Chief Executive Officer,
National Health & Medical Research Council, Australia (recorded video)
16.15
16.30
Policies and challenges for control of AMR in India| Jayaraman Gowrishankar| Centre for DNA Fingerprinting
and Diagnostics Department of Biotechnology, Ministry of Science and Technology, Government of India
Building a public national system for antimicrobial resistance surveillance in Argentina|
Marcelo Galas| Director, National Institute for Infectious Diseases, Argentina
16.45 Research going global – the EC´s readiness to lead the fight against AMR| Line Matthiessen| Head of Unit,
Infectious Diseases and Public Health Unit, DG Research and Innovation, European Commission
17.00 Open discussion and concluding remarks: presentation of Statement on AMR
18.00 Cocktail reception
Official Launch event of the JPIAMR Strategic Research Agenda
Lena Furmark, R NM. Sc. State Secretary, Ministry of Health and Social Affairs, Sweden
Mrs Furmark started her professional career as a Registered Nurse in 1980. She holds a Bachelor Degree in Political Science and Economics, a Degree in Common Law and a Degree in Healthcare Administration.Before joining the Ministry in 2010 Lena Furmark was the CEO of Caritea, a Swedish consultancy company focusing on business intelligence and healthcare change management.
Between 2002 and 2008, Mrs Furmark worked for Microsoft Corporation as Healthcare Business Development Manager in Sweden and Western Europe. Before that she was employed by the Federation of the County Councils in Sweden where she served as Director of the Executive Board Office. Mrs Furmark has also served as Director of Office in the Swedish Parliament and has had several expert- and consultancy assignments in Swedish parliamentary commissions and for the UN. Lena Furmark has served as a member of several boards i e Swedish Red Cross, Systembolaget, the Swedish Alcohol Retail Monopoly, and Swedish Pharmacy International Inc. She also has been the Chair of the Project Steering Board of the EpSOS project. www.epsos.eu
Máire Geoghegan-QuinnEuropean Commissioner for Research, Innovation and Science
Máire Geoghegan-Quinn has been the European Commissioner for Research, Innovation and Science since 2010. Between 2000 and 2010, she served as a Member of the Eropean Court of Auditors. From 1975 to 1997, she was a Member of the Irish parliament (Dáil Eireann). In 1979, she became the first woman to be appointed as a Cabinet Minister since the foundation of the Irish state, and served
as Minister with responsibility for the Gaeltacht until 1981. She has held various other ministerial posts, including Minister for European Union Affairs from 1987 to 1991, when she oversaw the preparation of the Irish presidency of the European Union in 1990; Minister for Tourism, Transport and Communications (1992-’93). She was the Irish Minister for Justice (1993-’94) and one of the negotiators of the Downing Street Declaration, which was signed between the Irish and British governments. From 1997 to 2000, Máire Geoghegan-Quinn served as Non-Executive Director of both Aer Lingus and the Ryan Hotel Group. She has been a TV presenter and a columnist in the Irish Times newspaper, and is a former Member of the Governing Authority of the National University of Ireland Galway.
Carmem PessoaHead of the AMR unit, World Health Organisation, Switzerland
Dr Carmem L. PESSOA-SILVA, MD, PhD, is Brazilian, joined the World Health Organization (WHO) in 2005. From January 2005 to November 2011 Dr Pessoa-Silva was the Team Leader for the WHO programme “Infection Prevention and Control in Health Care”. In the context of renewed efforts to combat antimicrobial drug resistance, WHO established the programme “Antimicrobial Drug Resistance”
in December 2011 and appointed Dr Pessoa-Silva to lead the new programme. Prior to WHO, Dr Pessoa-Silva gathered 20 years of professional experience as an infectious diseases physician in Brazil where she is an Associate Professor of Medicine at the Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
SPEAKERS´ BIOGRAPHIES
Official Launch event of the JPIAMR Strategic Research Agenda
Mats UlfendahlSecretary-General, Swedish Research Council, Sweden
Mats Ulfendahl (born 1959) is Secretary-General for medicine and health at the Swedish Research Council, and a member of the Council’s management team. He received his doctorate in physiology at Karolinska Institutet in 1989. In 2004 he was appointed professor of experimental audiology and otology (Karolinska Institutet). Dr. Ulfendahl was director of the Center for Hearing and Communication
Research from 2002 to 2010 when he was appointed Secretary-General. He serves on several national boards, including the board of The Swedish Council on Technology Assessment in Health Care and the National priority board for highly specialized health care. Dr. Ulfendahl was recently re-elected as Chair of the management board of JPIAMR, and he is the Swedish representative on the management board of JPND (Joint Programming on Neurodegenerative Disease Research). Dr. Ulfendahl is a member of the Governing Council of International Agency for Research on Cancer (IARC), Heads of International Research Organizations, and the High Level Group for Joint Programming (GPC).
Herman GoossensSAB Chair, University of Antwerp, Belgium
Herman Goossens is a professor of Medical Microbiology at the University of Antwerp in Belgium and the director of the Laboratory of Clinical Pathology of the University Hospital Antwerp. He received several honours and awards, including the American APUA (Alliance for the Prudent Use of Antibiotics) award in 2006. Herman Goossens published more than 450 full papers in peer-reviewed scientific
journals. He is the founder and Vice-Chair of the Belgian Antibiotic Policy Co-ordination Committee (BAPCOC). He coordinates several European projects funded by DG Research, DG SANCO, IMI and ECDC, such as Development of RApid Point-of-care test Platforms for Infectious Diseases (RAPP-ID), Platform for European Preparedness Against (Re-) emerging Epidemics (PREPARE), and LAB-Net of the Combating Bacterial Resistance in Europe project (COMBACTE). Herman Goossens was the organiser of the European Conference on Antibiotic Use in 2001 and of the European Conference on Health Care Associated Infections and Antibiotic Use in 2010, both on behalf of the Belgian EU Presidency. He is the founder of the annual European Antibiotic Resistance Day (EAAD) and chairs the Technical Advisory Committee at ECDC for EAAD. Herman Goossens was elected chair of the Scientific Advisory Board of the Joint Programming Initiative on Antimicrobial Resistance.
John WatsonDeputy Chief Medical Officer at the Department of Health, United Kingdom
Professor John Watson MB BS, MSc, FRCP, FFPH - is Deputy Chief Medical Officer for England and based at the Department of Health in London. He was previously a Consultant Clinical Epidemiologist and Head of the Respiratory Diseases Department at Public Health England’s Centre for Infectious Disease Surveillance and Control in London. He is an Honorary Professor in the Faculty
of Epidemiology and Public Health at the London School of Hygiene and Tropical Medicine and Visiting Professor in the Research Department of Infection and Population Health at University College London. He qualified from St Bartholomew’s Hospital Medical School, London, in 1979 and subsequently trained in clinical respiratory medicine and infectious disease epidemiology. His responsibilities span health protection with a particular focus on anti-microbial resistance, immunisation policy and emergency preparedness and response. His previous work focussed on the surveillance, prevention and control of tuberculosis and acute respiratory infections (particularly influenza, legionnaires disease and SARS) at the local, national and international levels as well as related research. He was a founder member in 2005, and Chairman from 2009 to 2013, of the International Society for Influenza and other Respiratory Virus Diseases (ISIRV).
Official Launch event of the JPIAMR Strategic Research Agenda
Richard BergströmDirector, EFPIA, Belgium
Richard Bergström has been the Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) since April 2011. Previously he served for nine years as the Director-General of LIF, the Swedish Association of the Pharmaceutical Industry, following positions in Switzerland in regulatory affairs at the pharmaceutical companies Roche and Novartis. Mr Bergström was also appointed by the
Swedish Government to the Board of the Karolinska Institute. He is a pharmacist by training, receiving his MScPharm degree from the University of Uppsala, Sweden in 1988.
Sir John SavillChief Executive of the Medical Reearch Council, United Kingdom
Professor Sir John Savill BA, MBChB, PhD, FRCP, FRCPE, FASN, FMedSci, FRSE, FRS, a clinician scientist from Edinburgh, took up the position as chief executive and deputy chair of the Medical Research Council (MRC) on 1 October 2010. He was a member of the MRC Council from 2002 to 2008 and chaired two MRC Research Boards during this period. Between 2008 and 2010 John worked part-time as the chief scientist for the
Scottish Government Health Directorates. He was knighted in the 2008 New Year’s Honours List for services to clinical science. John started his research career with a degree in Physiological Sciences from Oxford University in 1978, followed by degrees in Medicine at the University of Sheffield in 1981. He received a PhD from the University of London in 1989. After junior hospital appointments in Sheffield, Nottingham and London, he spent seven years in the Department of Medicine at Hammersmith Hospital with spells as an MRC clinical training fellow and Wellcome Trust senior clinical research fellow. In 1993, he moved to the chair of Medicine, at the University of Nottingham, then in 1998 became professor of Medicine at the University of Edinburgh, where he was the first director of the University of Edinburgh/MRC Centre for Inflammation Research, directing a group interested in the molecular cell biology of renal inflammation. In 2002, John was appointed as the first vice-principal and head of the College of Medicine and Veterinary Medicine, University of Edinburgh. He retains an ongoing, research active involvement with the University of Edinburgh part-time throughout his appointment as MRC chief executive.
Dennis M. DixonChief, Bacteriology and Mycology Branch, National Institute of Allergy and Infectious Diseases, NIH, USA
Dr. Dixon is Chief of the Bacteriology and Mycology Branch of the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Focus areas include antimicrobial resistance, health care associated infections, vector borne and zoonotic bacterial diseases, and fungal
diseases. Goals are to address public health needs through research that will improve diagnosis, prevention or treatment. Dr. Dixon serves on numerous federal advisory panels on Select Agents, the National Science Advisory Board for Biosecurity in various capacities, and the domestic and international Task Force on Antimicrobial Resistance. He received his doctorate in microbiology from the Medical College of Virginia in 1978. He held academic positions at Loyola College in Baltimore, the University of Maryland Medical School and Albany Medical College. He served as a Visiting Scientist at Hoffman LaRoche in Switzerland, and as Director for the Mycology Reference Laboratory at the New York State Department of Health. He is a member of the American Academy of Microbiology.
Official Launch event of the JPIAMR Strategic Research Agenda
Niresh BhagwandinExecutive Manager: Strategic Research Initiatives, South African Medical Research Council, South Africa
Niresh Bhagwandin has a PhD in Biomedical Engineering from the University of Cape Town and an MBA in Health Planning and Management from Keele University, UK. He is currently Executive Manager: Strategic Research Initiatives at the South African Medical Research Council (MRC) and a member of the MRC
Executive Management Committee. He also serves as the health, demographic change and wellbeing South African National Contact Point for the European Union Horizon 2020 programme.
Alain BeaudetPresident, Canadian Institutes of Health Research, Canada
Dr. Alain Beaudet, MD, PhD. is the President of the Canadian Institutes of Health Research (CIHR) since July 2008. Previously, he was the President and CEO of the Fonds de la recherche en santé du Québec (FRSQ).Among his many accomplishments, Dr. Beaudet was associate director (research) at the Montreal Neurological Institute (MNI). He was also Professor at McGill
University’s Neurology-Neurosurgery and Anatomy-Cell Biology departments. He has authored over 175 original articles and 40 monographs and book chapters. Dr. Beaudet has received numerous distinctions and awards, including two honoris causa doctorate degrees. He is a member of the National Order of Quebec and a Fellow of the Royal Society of Canada. Dr. Beaudet earned a medical degree and a PhD in neuroscience from the Université de Montréal. He completed his postdoctoral training in France and Switzerland. His career as a neuroscientist spanned from Neuroendocrinology to Pain, with a focus of the mechanisms of action of biogenic amines and neuropeptides in the brain.
Warwick AndersonChief Executive Officer, Ntional Health & Medical Research Council, Australia
Professor Warwick Anderson is the Chief Executive Officer (CEO) of NHMRC, Australia’s major governmental funding body for health and medical research. Previously, he was Head of School of Biomedical Sciences at Monash University and Deputy Director of the Baker Medical Research Institute, following research fellowships at the University of Sydney and Harvard Medical School.Professor
Anderson obtained his PhD from the University of Adelaide. His research has focused on renal causes of hypertension, including the roles of renal vascular remodeling, renal innervation and the renin-angiotensin system. He has published over 170 peer review articles.Professor Anderson is a member of the Prime Minister’s Science Engineering and Innovation Council, a Board member of the Global Alliance for Chronic Disease, a member of Heads of International (Biomedical) Research Organizations and of the National Lead Clinicians Group. He is an Honorary Fellow of the Royal College of Pathologists of Australasia and an International Fellow of the American Heart Foundation. He was made a Member of the Order of Australia in 2005.
Jayaraman GowrishankarCentre for DNA Fingerprinting and Diagnostics Department of Biotechnology, Ministry of Science and Technology, Government of India, India
Dr Gowrishankar graduated in medicine (1979) from the University of Madras (India) and completed his Ph.D (1983) in microbial genetics from the University of Melbourne (Australia). Since 1983, he has worked in Hyderabad, India as
Official Launch event of the JPIAMR Strategic Research Agenda
independent research investigator in E. coli microbiology, until 2000 at the Centre for Cellular and Molecular Biology and thereafter at the Laboratory of Bacterial Genetics in the Centre for DNA Fingerprinting and Diagnostics (CDFD). He has also been Director of CDFD since December 2005. His research interests have included studies on osmoregulation, solute transporters, biology of transposable elements, mutation mechanisms, and transcription-replication interplay. He is an elected Fellow of the Indian Academy of Sciences and of the Indian National Science Academy, and recipient of the American Society for Microbiology’s Moselio Schaechter Award for Distinguished Service.
Marcelo GalasDirector, National Institute for Infectious Diseases, Argentina
Dr. Galas, Chief of Bacteriology Department at the National Institute of Infectious Diseases, is the General Coordinator of the Bacteriology Laboratory Networks System This system include the following national thematic surveillance networks: Bacterial Meningitis and Respiratory Tract Infections, Diarrhoea and Food Transmited Infections, Sexualy Transmited Infections, Brucella Infections,
Tuberculosis Infections and the WHONET-Argentina network for Antimicrobial Resistance Surveillance. He also is the manager of the last thematic network. At the Malbrán Institute, Dr. Galas has specialized in antimicrobial resistance, especially in clinical diagnosis, characterization of mechanisms of action and resistance, and surveillance. One of his greatest contributions was improving the quality of clinical diagnostic services in Argentina, including establishment of a national program of external quality assessment. Quality indicators over the past 15 years have demonstrated a decrease in diagnostic errors from over 10% to less than 1%. Dr. Galas has collaborated with the Pan American Health Organization to introduce this successful model to nearly all Institutes of Health in Latin America. Currently Dr. Galas is responsible for the coordination and integration of all bacteriological networks of the National Institute of Infectious Diseases orientated to the improvement of clinical diagnosis in health centers, introduction of molecular diagnostic methodologies, characterization of human pathogens and the detection and characterization of both hospital and community outbreaks. The introduction of new diagnostic methods with extensive training of laboratory professionals has improved the accuracy of diagnostic laboratories across the country. Areas of expertise include clinical and molecular aspects of infectious diseases and antimicrobial resistance, building capacity for bacteriological diagnostic, surveillance and quality assurance management.
Line MatthiessenHead of Unit, Infectious Diseases and Global EpidemicsDirectorate E – Health, DG Research & Innovation, European Commission
Dr Line Matthiessen leads the Unit responsible for Infectious Diseases and Public Health in the Directorate-General for Research and Innovation. The Unit promotes and supports EU research and innovation activities in the area of global health issues with emphasis on HIV/AIDS, malaria and tuberculosis, emerging epidemics,
neglected infectious diseases and antimicrobial drug resistance, as well as activities in public health and health systems research. The Unit also supports the implementation of the European and Developing Countries Clinical Trials Partnership (EDCTP). Dr Matthiessen was Head of Unit for horizontal aspects and coordination in the Directorate for Biotechnologies, Agriculture and Food Research from 1 July 2007 to December 2010. Dr Matthiessen joined the European Commission in 1992. She has been responsible for strategic and policy issues in biotechnology. She held the position as principal scientific officer responsible for research in Neurosciences for several years. She has also been scientific officer in the area of Somatic gene therapy, Animal cell technology and in vitro testing as alternatives to animal experiments. Dr Line Matthiessen was trained as an MD at the University of Odense, Denmark and received her PhD in Neurosciences from the University of Paris VI, France in 1993.
Official Launch event of the JPIAMR Strategic Research Agenda
MODERATORS
Fulvio EspositoChair GPC and Head of Technical Secretariat of the Minister for Education, University and Research, Italy
Born in Viareggio (Italy) in 1951, full professor of Parasitology at Camerino University (UNICAM) since 1987, Fulvio Esposito developed his scientific background in Pisa University and Scuola Normale Superiore, where he obtained his MSc and PhD in Biology, respectively. His scientific contributions on
various aspects of malaria include immunology and immunotechniques, epidemiology and control, parasitology, entomology. The results he obtained with insecticide-treated netting on child mortality prompted the World Health Organization to adopt and promote this malaria control strategy in endemic countries, particularly in Africa. Some of the doctoral candidates he supervised are now among the leading African scientists, awarded with prestigious international prizes. In UNICAM, he has been the Dean of the Faculty of Science & Technology (1998 – 04) and Rector (2004 – 11).He is collaborating as an expert with the European Commission and representing Italy on subjects related to researchers and research, as member of the ‘Steering Group on Human Resources and Mobility’, and has been elected as Chair of the ‘High level group on Joint Programming of European Research (GPC)’. From July 2013 to February 2014, he has headed the Technical Secretariat of the Minister for Education, University and Research.
Laurent GutmannHead of microbiological Laboratory at the European Hospital Georges Pompidou, France
Laurent Gutmann is MD-PhD .Professor of Microbiology, Head of microbiological Laboratory at the European Hospital Georges Pompidou in Paris, He was Head of Reference Center for Pneumococci (France 1999-2011). He is part of an INSERM research unit [UMRS 872] working on the molecular basis of the resistance to
antibiotics oriented towards the cell wall targets. He was counsellor of the INSERM director for infectious diseases and microbiology. He is presently member of the scientific board of the French thematic institute IMMI (Microbiology and infectious diseases) and member of the JPI-AMR management board.
André Van der ZandeDirector-General at RIVM, The Netherlands
Prof. Dr André van der Zande, PhD (1952) is Director-General at RIVM. He has held this position since 1 January 2011. ”Committed to health and sustainability”. André van der Zande studied biology at Leiden University and graduated with distinction in 1976. In 1984 he was awarded his PhD from the same university on the subject of the field of tension between recreation and bird conservation.
From 1986 onwards he managed various large knowledge institutes in Wageningen, among them Alterra. In addition he was a part-time professor of Spatial Planning and Cultural History under the Belvedère programme at Wageningen University (2005-2009). In 2002 André Van der Zande made the changeover to the former Dutch Ministry of Agriculture, Nature and Food Quality (ministerie van Landbouw, Natuur en Voedselkwaliteit - LNV). Until 2007 he was Director-General at the LNV and his responsibilities included agricultural policy, nature and biodiversity, manure policy and general environmental policy. In 2007 he became Secretary-General there, until the merger of the LNV with the Dutch Ministry of Economic Affairs.
Official Launch event of the JPIAMR Strategic Research Agenda
Marc OueletteScientific Director, Canadian Institutes of Health Research, Canada
Dr. Ouellette is the Scientific Director of the Institute of Infectious Disease and Immunity of CIHR since January 1st, 2010. In this capacity, he has led the conception and implementation of several research initiatives in the areas of organ transplantation, inflammation, microbiome, vaccines and antibiotic resistance. Dr. Ouellette also oversees the development and outcomes of the HIV/AIDS
and Hepatitis C Research Initiatives.Dr. Ouellette obtained his Bachelor of Science (Honours) in Biochemistry at Ottawa University and received his PhD at Laval University on antibiotic resistance in bacteria. His postdoctoral studies were done under the mentorship of Pr. Piet Borst of the Netherlands Cancer Institute in Amsterdam, where he further developed his expertise in antimicrobial resistance studying protozoan parasites. In 1990 he joined the Centre de Recherche en Infectiologie, of Laval University as an Assistant professor and is now full professor. Dr. Ouellette’s research is focused on antimicrobial resistance where he has made seminal discoveries on resistance mechanism in protozoan parasites. More recently he has implemented proteomic and DNA microarray strategies to study antimicrobial resistance in the parasite Leishmania and the bacteria Streptococcus pneumoniae.Dr. Ouellette has received numerous awards for his work including a New Investigator Award in Molecular Parasitology from the Burroughs Wellcome Fund, a MRC Scientist Award, a Scholar Award in Molecular Parasitology of the Burroughs Wellcome Fund, and a Tier 1 Canada Research Chair in Antimicrobial Resistance. He is a Fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences. He has served on numerous panels of national and international granting agencies and is a strong supporter of scientific exchanges with developing countries.
Official Launch event of the JPIAMR Strategic Research Agenda
LIST OF PARTICIPANTS
Herman Goossens
Richard Bergström
University of Antwerp, Belgium EFPIA
[email protected] [email protected]
Dennis M. Dixon Carmem Pessoa
National Institute of Allergy and Infectious Diseases, USA World Health Organisation
[email protected] [email protected]
Marc Ouellette Alain Beaudet
Canadian Institutes of Health Research, Canada Canadian Institutes of Health Research, Canada
[email protected] [email protected]
Marcelo Galas Mats Ulfendahl
National Institute for Infectious Diseases, Argentina Swedish Research Council, Sweden
[email protected] [email protected]
Niresh Bhagwandin Line Matthiessen
South African Medical Research Council, South Africa European Commission
[email protected] [email protected]
Jayaraman Gowrishankar Fulvio Esposito
Government of India University of Camerino, Norway
[email protected] [email protected]
Lena Furmark Karl-Olaf Wathne
Ministry of Health and Social Affairs, Sweden Ministry of Health and Care Services, Norway
[email protected] [email protected]
Sir John Savill Lene Cividanes
Medical Research Council, United Kingdom The Danish Council for Strategic Research, Denmark
[email protected] [email protected]
John Watson Gloria Villar
Department of Health, United Kingdom Instituto de Salud Carlos III, Spain
[email protected] [email protected]
Antoine Andremont Sally Donaldson
Hôpital Bichat-Claude Bernard, France ERC
Official Launch event of the JPIAMR Strategic Research Agenda
Jane Knisely
Martijntje Bakker
National Institute of Allergy and Infectious Diseases, USA ZonMW, The Netherlands
[email protected] [email protected]
Bertrand Schwartz Ayse Özge Gozay
ANR (National Agency for Research), France TUBITAK, Turkey
Laurent Gutmann Jaana Vuopio
Inserm/Aviesan, France Academy of Finland, Finland
[email protected] [email protected]
Andreas Aeschlimann Ahmi Ben-Yehudah
Federal Department of Economic Affairs, Switzerland Ministry of Health, Israel
[email protected] [email protected]
Anita Janelm Hajo Grundmann
Social Ministry, Sweden UMCG, Groningen, The Netherlands
[email protected] [email protected]
Niels Frimodt-Møller Luis Valente
Statens Serum Institut, Denmark FCT, Portugal
[email protected] [email protected]
Mattias Norrby Desmond Walsh
Formas, Sweden Medical Research Council, United Kingdom
[email protected] [email protected]
Dunja Dreesens Ghada Zoubiane
ZonMW, The Netherlands Medical Research Council, United Kingdom
[email protected] [email protected]
Waleria Hryniewicz Ewa Sadowy
National Medicines Institute, Poland National Medicines Institute, Poland
[email protected] [email protected]
Bülent Genc Arjon van Hengel
Forschungszentrum Jülich GmbH, Germany European Commission
Official Launch event of the JPIAMR Strategic Research Agenda
Bruno Gonzalez-Zorn
Jan Vaarten
Universidad Complutense de Madrid, Spain Federation of Veterinarians of Europé, Belgium
[email protected] [email protected]
Danilo Lo Fo Wong Ceyssens Pieter-Jan
World Health Organization, Denmark Scientific Institute of Public Health, Belgium
[email protected] [email protected]
Andreas Krell Magda Chlebus
Europ. Liaison Office of the German Research Org., Belgium EFPIA
[email protected] [email protected]
Remko van Leeuwen S.A.J. Zaat
AIGHD, The Netherlands Academic Medical Center, The Netherlands
[email protected] [email protected]
Constance Schultsz Robin Moudy
University of Amsterdam, The Netherlands AAAS S&T Policy Fellow
[email protected] [email protected]
Maurice Samuel Devaraj Seamus O'Brien
India AstraZeneca, United Kingdom
[email protected] [email protected]
Judith Hackett Hubert P ENDTZ
Astrazeneca, Inc., USA Fondation Mérieux, France
[email protected] [email protected]
Mathias Winterhalter Patricia Paukovits
Jacobs University Bremen (BTW: IMI-Topic 2), Germany European Commission DG RTD
[email protected] [email protected]
Anders Karlén Jean-Charles Cavitte
Uppsala University, Sweden European Commission
[email protected] [email protected]
Carlos Arauzo Burillo Xavier Daura
European Commission DG RTD/F3 Universitat Autònoma de Barcelona, Spain
[email protected] [email protected]
Miguel Vicente Alana Yuill
Centro Nacional de Biotecnología-CSIC, Spain Canadian Institutes of Health Research, Canada
Official Launch event of the JPIAMR Strategic Research Agenda
Philippe Kagan
Thomas Allvin
EIE, France Permanent Repr. of Sweden to the EU, Sweden
[email protected] [email protected]
Liselotte De Vos Laura Marin
Departement EWI, Flemish Government, Sweden Swedish Research Council, Sweden
[email protected] [email protected]
Ruth Kelly Paul Williams
MRC/ JPIAMR, United Kingdom University of Nottingham, United Kingdom
[email protected] [email protected]
Tim Walsh Sofia Kuhn
Cardiff University, United Kingdom Muninn Science Communication, Belgium
[email protected] [email protected]
Pontus Holm Cecilia Mattsson
Swedish Research Council, Sweden Swedish Research Council, Sweden
[email protected] [email protected]
Mikaela Laine Paola Norlin
Swedish Research Council, Sweden Swedish Research Council, Sweden
[email protected] [email protected]
Jenny Maukola Gazelle Gaignaire
Research Europé, United Kingdom e-gazelle, Belgium
[email protected] [email protected]
André Van der Zande Giorgio Clarotti
RIVM European Commission
[email protected] [email protected]
Richard Bax Carsten Strøby Jensen
Transcrip-partners.com, Belgium University of Copenhagen, Denmark
[email protected] [email protected]
Gregoire Tallard Martin Steinbakk
OECD, France Norwegian Institute for Public Health, Norway
[email protected] [email protected]
Tim Walsh
Cardiff University
[email protected] ©Photo: Photography cover: Cover by Shutterstock, Mikael Damkier, Edwin Verin, Molecule mureidomycin A via E.Ruijter, cow via J.Wagenaar, medical specialists via S. Geerlings, petri dish via D. Mevius.